As drug developers pursue increasingly complex therapies, traditional bioanalytical approaches are being put to the test. How is the field adapting to meet these new demands?
Intravacc offers four complementary vaccine development platforms: bacterial vaccines, viral vaccines, conjugate vaccines, and E.coli expressed ...
Henny Zijlstra, Chief Commercial Officer of Ardena, discusses the integrated CDMO model, Ardena’s new laboratory in New ...
Umbrella Labs today issued a company announcement confirming an internal documentation and traceability update for PT-141 ...
Umbrella Labs today issued a company announcement confirming an internal documentation and traceability update for bromantane reference material, provided strictly for laboratory developmental ...
An investigation ensued to determine the cause of death. 1 Autopsy findings included no observable signs of external trauma, ...
Cannabix Technologies (CSE:BLO)(USOTC:BLOZF)(Frankfurt: 8CT)has announced a potentially transformative advancement in the ...
A slew of start-ups and academic labs are leaning on AI agents and bots, rather than humans, to speed up their chemistry ...
Analyzing thousands of proteins from a single drop of blood is no longer science fiction. High-throughput proteomics has transformed biomarker discovery by enabling simultaneous profiling of thousands ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results